Clinical trial
Multicentre Randomised Double-blind, Placebo-controlled 2x2 Factorial Trial Investigating the Effects of Adding Mirtazapine and Folic Acid to Existing Therapy for Patients With Schizophrenia
NCT01263080 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre Randomised Double-blind, Placebo-controlled 2x2 Factorial Trial Investigating the Effects of Adding Mirtazapine and Folic Acid to Existing Therapy for Patients With Schizophrenia
- Lead sponsor
- Capital Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 333 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.